“Alzheimer’s is open for business:” Controversial FDA approval could pave the way for future drugs
On Monday, a 17-year drought in the world of Alzheimer’s drugs ended with the FDA approval of Biogen’s Aduhlem (aducanumab).…
Extra Crunch roundup: Security data lakes, China vs. Starlink, ExtraHop’s $900M exit
News broke this morning that Bain Capital Private Equity and Crosspoint Capital Partners are purchasing Seattle-based network security startup ExtraHop.…
FDA approves first new Alzheimer’s drug in almost 20 years
Usefulness of aducanumab is disputed but US approval will trigger push to make it available globally A controversial new drug…
Singapore-based D2C dental brand Zenyum raises $40M Series B from L Catterton, Sequoia India and other investors
Zenyum, a startup that wants to make cosmetic dentistry more affordable, announced today it has raised a $40 million Series…
Doximity
EC Enterprise Health
EC Newsletter
Fundings & Exits
Health
HealthTech
Startups
telehealth
The Exchange
Doximity’s S-1 may explain why healthcare exits are heating up
There was a time when this column was more than a never-ending run of IPO coverage. Then the unicorn liquidity…
Ada Health
Artificial Intelligence
berlin
digital health
Europe
Germany
Health
healthcare
Leaps by Bayer
Pharmaceutical
samsung catalyst fund
Science and Technology
sutter health
TC
Vitruvian Partners
Ada Health closes $90M Series B led by Leaps by Bayer
The digital health space continues cooking on gas: Berlin-based Ada Health has closed a $90M Series B round of funding…